About ObvioGo - Clinical Research
The ObvioGo™ app is a purpose-built mobile application designed to make clinical trial participation as easy and seamless as possible. As a pivotal piece of ObvioHealth’s configurable decentralized clinical trial (DCT)...
The ObvioGo™ app is a purpose-built mobile application designed to make clinical trial participation as easy and seamless as possible. As a pivotal piece of ObvioHealth’s configurable decentralized clinical trial (DCT) platform, this app enables participants to engage in clinical studies outside the traditional trial setting—from the comforts of home and as they go about their daily lives. The app’s features allow participants to provide consent, complete study tasks, report changes in health or medication, and communicate with the study team, all from the convenience of their personal Android mobile devices. The result? A seamless participant experience powered by user-friendly, intuitive tools.
Previous Versions
Here you can find the changelog of ObvioGo - Clinical Research since it was posted on our website on 2024-07-29 16:41:42.
The latest version is 1.4.16 and it was updated on 2026-10-12 18:50:20. See below the changes in each version.
ObvioGo - Clinical Research version 1.4.16
Updated At: 2025-02-12
Changes: Bug fixes & improvements
ObvioGo - Clinical Research version 1.4.13
Updated At: 2024-10-17
Changes: Bug fixes and improvements
Disclaimer
Official Google Play Link
We do not host ObvioGo - Clinical Research on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Google and passed their terms and conditions to be listed there. We recommend caution when installing it.
The Google Play link for ObvioGo - Clinical Research is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
